Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 11:43 am Sale |
2021-12-31 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Eventide Asset Management, LLC | 590,602 1.200% |
-288,939![]() (-32.85%) |
Filing History |
2022-02-14 11:41 am Purchase |
2021-12-31 | 13G | Zymeworks Inc. ZYME |
Eventide Asset Management, LLC | 2,819,135 6.100% |
2,819,135![]() (New Position) |
Filing History |
2022-02-14 11:39 am Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 2,850,000 7.400% |
845,384![]() (+42.17%) |
Filing History |
2022-02-14 11:37 am Purchase |
2021-12-31 | 13G | VectivBio Holding AG VECT |
Eventide Asset Management, LLC | 2,339,044 6.700% |
2,339,044![]() (New Position) |
Filing History |
2022-02-14 11:35 am Purchase |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Eventide Asset Management, LLC | 3,742,507 9.600% |
3,742,507![]() (New Position) |
Filing History |
2022-02-14 11:33 am Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Eventide Asset Management, LLC | 3,514,909 8.800% |
3,514,909![]() (New Position) |
Filing History |
2022-02-10 4:18 pm Purchase |
2022-01-31 | 13G | KnowBe4, Inc. KNBE |
Eventide Asset Management, LLC | 4,177,983 10.100% |
4,177,983![]() (New Position) |
Filing History |
2021-02-12 4:19 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 2,335,168 7.000% |
324,999![]() (+16.17%) |
Filing History |
2021-02-12 4:16 pm Sale |
2020-12-31 | 13G | ARYA SCIENCES ACQUISITION CORP ARYAU |
Eventide Asset Management, LLC | 0 0.000% |
-800,000![]() (Position Closed) |
Filing History |
2021-02-12 4:15 pm Sale |
2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Eventide Asset Management, LLC | 1,000,000 2.100% |
-2,393,894![]() (-70.54%) |
Filing History |
2021-02-12 4:13 pm Sale |
2020-12-31 | 13G | STEMLINE THERAPEUTICS INC STML |
Eventide Asset Management, LLC | 0 0.000% |
-4,160,608![]() (Position Closed) |
Filing History |
2021-02-12 4:13 pm Purchase |
2020-12-31 | 13G | Vital Farms, Inc. VITL |
Eventide Asset Management, LLC | 2,053,232 5.200% |
2,053,232![]() (New Position) |
Filing History |
2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Eventide Asset Management, LLC | 234,205 9.200% |
234,205![]() (New Position) |
Filing History |
2021-02-12 4:11 pm Purchase |
2020-12-31 | 13G | Pliant Therapeutics, Inc. PLRX |
Eventide Asset Management, LLC | 2,838,125 8.000% |
2,838,125![]() (New Position) |
Filing History |
2021-02-12 4:10 pm Purchase |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 2,370,975 5.300% |
1,126,080![]() (+90.46%) |
Filing History |
2021-02-12 4:08 pm Purchase |
2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Eventide Asset Management, LLC | 138,000 6.200% |
138,000![]() (New Position) |
Filing History |
2021-02-12 4:07 pm Sale |
2020-12-31 | 13G | Zogenix, Inc. ZGNX |
Eventide Asset Management, LLC | 0 0.000% |
-2,841,300![]() (Position Closed) |
Filing History |
2021-02-12 4:07 pm Purchase |
2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 165,710 7.500% |
165,710![]() (New Position) |
Filing History |
2021-02-12 4:06 pm Purchase |
2020-12-31 | 13G | Chiasma, Inc. CHMA |
Eventide Asset Management, LLC | 3,000,326 5.200% |
3,000,326![]() (New Position) |
Filing History |
2021-02-12 4:05 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 2,004,616 5.300% |
2,004,616![]() (New Position) |
Filing History |